Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease rheumatoid arthritis
Symptom C0038012|spondylitis
Sentences 8
PubMedID- 23626604 In contrast to pamidronate studies in ankylosing spondylitis, use of pamidronate in rheumatoid arthritis had rapid onset of action which appeared before 3 months of treatment.
PubMedID- 25851594 The goal of the study was to compare the drug survival and the causes of discontinuation of anti-tumoral necrosis factor (anti-tnf) therapy in ankylosing spondylitis (as) with rheumatoid arthritis (ra).
PubMedID- 23108113 Odds of rheumatoid arthritis, ankylosing spondylitis, lupus, crohn's disease and multiple sclerosis were not significantly increased in patients with severe psoriasis.
PubMedID- 22737386 rheumatoid arthritis, ankylosing spondylitis), tnf-α concentration is elevated in affected joints, which seems to play a prominent role in joint destruction.
PubMedID- 21876969 rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis disease activity parameters were comparable in both groups (p>0.05).
PubMedID- 24646632 More specifically, the hla complex appears to be important in the clinical expression of insulin dependent diabetes mellitus, reiter’s syndrome, especially hla-b27 associated ankylosing spondylitis and hla-dr4 with rheumatoid arthritis .
PubMedID- 23526916 This study takes its cue from commissary decree n. 26 of 14 march 2012 (region of campania, italy), on the appropriateness of biologics used to treat psoriasis and psoriatic arthritis, rheumatoid arthritis, ankylosing spondylitis, and chronic inflammatory diseases of the intestinal tract both in adult and pediatric patients, excluding therefore biological drugs prescribed for tumor pathologies.
PubMedID- 25954039 rheumatoid arthritis, ankylosing spondylitis, inflammatory bowel disease, psoriasis (bnf, 2015)infection, lymphoma, demyelinating disease, autoantibody induction, congestive heart failure, injection site reactions, lupus-like syndrome (scheinfeld, 2004)granulocyte-colony stimulating factor (g-csf)net price 600 mcg/ml £52.70, 0.5-ml prefilled syringe (bnf, 2015)neutropenia (various clinical types), severe or recurrent infections in advanced human immunodeficiency virus infection (bnf, 2015)mucositis, splenic enlargement, hepatomegaly, transient hypotension, epistaxis, urinary abnormalities, osteoporosis, exacerbation of rheumatoid arthritis, anaemia, pseudogout (bnf, 2015)bnf, british national formulary; doh, department of health; fda, food and drug administration.

Page: 1